Clinical Trial

Glycemia and Ischemia Reperfusion Brain Injury in Patients With Acute Cerebral Infarction Treated With Mechanical Thrombectomy

Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 24, 2026 (before its estimated July 15, 2026 completion). Its status may not reflect the trial's current state.
Summary
Postictus hyperglycemia is associated with an accelerated transformation of the ischemic penumbra into an infarct area, with increased infarct size, worse recanalization, reduced cerebral perfusion, increased ischemia reperfusion damage, and worse outcome. Furthermore, when perfusion is reinstated, hyperglycemia causes secondary tissue damage through an increase in ischemic reperfusion damage. Thus, those patients with glycemia values \< 155 mg/dL during mechanical thrombectomy, and especially at the time of reperfusion, will have greater ischemia-reperfusion damage, showing a different profile in miRNA expression, with better neurological and functional outcomes and higher risk of hemorrhagic transformation and cerebral edema. The main objective of the study is to evaluate the association between glycemia values at the time of reperfusion and stroke recovery at 3 months in patients with acute cerebral infarction treated with mechanical thrombectomy.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2023-05-12.
Status change: Recruiting → Active, Not Recruiting 2026-04-21
Trial Details
NCT Number NCT05871502
Lead Sponsor Instituto de Investigación Hospital Universitario La Paz
Conditions Cerebral Infarction
Enrollment 100 participants
Start Date 2023-04-13
Primary Completion 2026-07-15 (estimated)
Study Completion 2026-07-15 (estimated)
Updated on ClinicalTrials.gov 2026-04-24